Abstract
AMIODARONE IS an antiarrhythmic that commonly is indicated in the cardiothoracic surgical intensive care unit for the management of atrial fibrillation. 1 Boons J Van Biesen S Fivez T et al. Mechanisms, prevention and treatment of atrial fibrillation after cardiac surgery: A narrative review [epub ahead of print]. J Cardiothorac Vasc Anesth. 2021; (Accessed June 14th 2021)https://doi.org/10.1053/j.jvca.2020.11.030 Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar ,2 Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation. Circulation. 2012; 125: 381-389 Crossref PubMed Scopus (153) Google Scholar Acute lung injury associated with amiodarone exposure is a rare but life-threatening syndrome that may complicate perioperative management. 3 Feduska ET Thoma BN Torjman MC et al. Acute amiodarone pulmonary toxicity. J Cardiothorac Vasc Anesth. 2021; 35: 1485-1494 Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar This case conference presents a complex clinical scenario that included acute pulmonary toxicity in the setting of amiodarone therapy for atrial fibrillation. The subsequent expert commentaries explore the diagnostic and management options for this pharmacologic complication in light of the recent literature.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
